Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis

BACKGROUND: An estimated 170 million people worldwide are infected with hepatitis C virus (HCV). HCV genotype 4 (HCV-4)—the most prevalent hepatitis C strain in the Middle East and Africa—is difficult to treat, with an estimated sustained virological response (SVR) of 53% when using pegylated interf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bing, Nguyen, Nghia H, Yee, Brittany E, Yip, Benjamin, Nguyen, Mindie H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650907/
https://www.ncbi.nlm.nih.gov/pubmed/26629360
http://dx.doi.org/10.1136/bmjgast-2015-000057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650907/
https://www.ncbi.nlm.nih.gov/pubmed/26629360
http://dx.doi.org/10.1136/bmjgast-2015-000057

Ejemplares similares